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background: Anticoagulation therapy with warfarin is effective in the prevention of ischemic strokes in patients with atrial fibrillation (AF) but 
predisposes to intracranial bleedings.
methods: In this retrospective study data from 1,867 patients with a history of AF and ischemic stroke, transient ischemic attack (TIA) or 
intracranial bleeding during 2003-2012 was analyzed. A total of 596 out of the 1,867 patients suffered 158 intracranial bleeds, 452 ischemic 
strokes and 151 TIA while on warfarin treatment.
results: The international normalized ratio (INR) was above the therapeutic range in 31.6 % of the cases with intracranial bleeding, and 34.8 % 
of the bleeds were fatal within 1 month (Table). In patients with an ischemic event INR was < 2.0 in 45.6% of the cases. Patients who suffered an 
ischemic event had a higher CHA2DS2VASc score than patients who suffered an intracranial bleeding, but there was no difference in the HASBLED 
score. Severe renal insufficiency was more common in patients with intracranial bleeding.
conclusion: Over-anticoagulation was common in patients with intracranial bleeding and under-anticoagulation in patients with an ischemic 
event. Severe renal insufficiency was more common in patients with intracranial bleeding. HASBLED score was unable to identify patients who 
developed intracranial hemorrhage.
Intracranial bleedings, TIA episodes and ischemic strokes during warfarin treatment
Intracranial bleeding
n (%)
Ischemic stroke or TIA
n (%)
p
N (% of all events) 158 (20.8) 452 (59.4) Ischemic strokes and 151 (19.8) TIA
Age, yr (95% CI) 78.6 (77.3-79.8) 77.4 (76.7-78.7) .12
Female gender 77 (48.7) 320 (53.1) .33
CHA2DS2VASc score (95% CI) 3.80 (3.57-4.04) 4.12 (3.99-4.25) .03
INR < 2.0 22 (13.9) 275 (45.6) <.001
INR > 3.0 50 (31.6) 51 (8.5) <.001
HASBLED score (95% CI) 2.40 (2.23-2.57) 2.27 (2.19-2.34) .17
HASBLED ≥ 3 62 (39.2) 232 (38.5) .86
Aspirin 17 (10.8) 85 (14.1) .32
Previous stroke or TIA 47 (29.9) 248 (41.3) .01
History of bleeding 9 (5.7) 21 (3.5) .28
Alcohol abuse 6 (3.8) 9 (1.5) .061
GFR < 30 (ml/min) 11 (7.3) 17 (3.0) .015
Death in 1 month after stroke 54 (34.8) After ischemic stroke 55 (12.2) <.0001
